Company Filing History:
Years Active: 2009-2012
Title: The Innovations of Christophe Schneider in Angiogenesis Research
Introduction
Christophe Schneider is a notable inventor based in Reims, France, with a strong focus on the field of angiogenesis. He has made significant contributions through his innovative research, leading to the filing of three patents that explore therapeutic compositions aimed at regulating angiogenesis. His work aims to improve the understanding and treatment of various angiogenic disorders, showcasing his commitment to advancing medical science.
Latest Patents
Among Christophe Schneider's latest patents, one notable invention is the "Composition comprising an antisense sequence implicated in the regulation of angiogenesis." This patent describes therapeutic compositions that include nucleotide sequences of genes known to play a role in the angiogenesis mechanism. These compositions also involve polypeptide sequences coded by the mentioned genes, along with antibodies targeting these polypeptides. Furthermore, the invention relates to genetically modified cells that either underexpress or overexpress these genes, providing methods for diagnosing and treating angiogenic disorders.
Another significant patent is the "Composition comprising an angiogenesis-related protein." This work identifies nucleotide sequences and corresponding polypeptide sequences that are crucial to the regulation of angiogenesis. The patent outlines the application of these sequences in clinical studies for diagnosing, prognosing, and treating pathologies linked to angiogenesis, along with their potential use in pharmacological and drug identification trials.
Career Highlights
Christophe Schneider's professional journey includes pivotal roles at Gene Signal International SA and Gene Signal, where he has collaboratively worked on cutting-edge projects in the field of biotechnology. His innovative spirit and research acumen have positioned him as a key contributor to advancements in medical research, particularly in angiogenesis.
Collaborations
Throughout his career, Christophe has collaborated with esteemed colleagues, including Salman Al-Mahmood and Sylvie Colin. Their partnerships have further enriched his research, allowing for the exchange of ideas and the development of groundbreaking solutions in the realm of angiogenesis.
Conclusion
Christophe Schneider's inventive contributions to the field of angiogenesis through his patents demonstrate a remarkable blend of innovation and scientific inquiry. His commitment to improving therapies for angiogenic disorders not only reflects his dedication as an inventor but also exemplifies the transformative potential of research in medicine. Through his work, Schneider continues to pave the way for future innovations that could significantly impact patient care and therapeutic approaches.